Panacea Biotec

First-ever phase-three clinical trial for dengue vaccine initiated in India

First-ever phase-three clinical trial for dengue vaccine initiated in India

14 Aug 2024

2 min read

Adar Poonawalla exits Panacea Biotec, sells entire stake for Rs 118 cr

Adar Poonawalla exits Panacea Biotec, sells entire stake for Rs 118 cr

17 May 2021

1 min read

Panacea Biotec joins hands with US-based Refana to develop COVID-19 vaccine

Panacea Biotec joins hands with US-based Refana to develop COVID-19 vaccine

10 Jun 2020

1 min read

DT Next

www.dtnext.in